Patients with Growth-Related Disorders and Caregivers Prefer the Somapacitan Device to the Somatrogon Device: Results from a Randomized Crossover Study Assessing Device Preference and Ease of Use Following Simulated Injections

Shahid Akhtar,1 Birgitte Berg,2 Johan Medina,3 Maya Nicole Gonczi,4 Sophie Hamilton,5 Emily Hildebrand,4 Nicky Kelepouris,6 Jesper Skov Neergaard,7 Claus Sværke,8 Gitte Ter-Borch,2 Niklas Kahr Rasmussen3 1Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark; 2Clinical Operations, Obesity, Liv...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Akhtar S, Berg B, Medina J, Gonczi MN, Hamilton S, Hildebrand E, Kelepouris N, Neergaard JS, Sværke C, Ter-Borch G, Rasmussen NK
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Dove Medical Press 2024-10-01
Sraith:	Medical Devices: Evidence and Research
Ábhair:	growth hormone deficiency long-acting growth hormone device preference ease of use somapacitan somatrogon
Rochtain ar líne:	https://www.dovepress.com/patients-with-growth-related-disorders-and-caregivers-prefer-the-somap-peer-reviewed-fulltext-article-MDER
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!